Skip to main content
Top
Published in: Annals of Nuclear Medicine 3/2015

01-04-2015 | Original Article

Differentiation of an adrenal mass in patients with non-small cell lung cancer by means of a normal range of adrenal standardized uptake values on FDG PET/CT

Authors: Bom Sahn Kim, Jong Doo Lee, Won Jun Kang

Published in: Annals of Nuclear Medicine | Issue 3/2015

Login to get access

Abstract

Object

The aim of this study was to assess the range of normal adrenal FDG uptake, and to determine the diagnostic criteria of FDG PET-CT to differentiate adrenal nodule.

Methods

A total of 117 healthy subjects who underwent FDG PET/CT for cancer screening, and 106 lung cancer patients who underwent FDG PET/CT for cancer staging without adrenal abnormality were enrolled to determine the normal range of adrenal standardized uptake value (SUV). In addition, another 24 lung cancer patients with suspicious adrenal masses were enrolled to evaluate the diagnostic performance of the different diagnostic criteria from FDG PET/CT.

Results

The adrenal maximal SUV (SUVmax) of the healthy group was 1.66 ± 0.21 in the right and 1.86 ± 0.30 in the left. The adrenal SUVmax of lung cancer group was 1.79 ± 0.30 in the right and 1.90 ± 0.37 in the left. Lung cancer group had a higher ratio of adrenal gland to liver (AL ratio) when compared with healthy subjects (0.77 ± 0.13 vs. 0.61 ± 0.10 on the right, 0.82 ± 0.12 vs. 0.68 ± 0.12 on the left: p < 0.001). The upper normal limits of adrenal SUVmax were calculated as the mean plus 2 standard deviations (right: 2.08 vs. 2.39, left: 2.46 vs. 2.64, in the normal group and lung cancer group, respectively). Using the upper limit from the lung cancer group, we achieved a sensitivity of 87 % and specificity of 100 %.

Conclusion

We demonstrated that left adrenal gland had higher SUV than right adrenal gland both in healthy group and lung cancer group. Using the different normal range of bilateral adrenal SUVmax, we could successfully differentiate adrenal masses.
Literature
1.
go back to reference Barzon L, Sonino N, Fallo F, Palu G, Boscaro M. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol. 2003;149:273–85.CrossRefPubMed Barzon L, Sonino N, Fallo F, Palu G, Boscaro M. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol. 2003;149:273–85.CrossRefPubMed
2.
go back to reference Ettinghausen SE, Burt ME. Prospective evaluation of unilateral adrenal masses in patient with operable non-small cell lung cancer. J Clin Oncol. 1991;9:462–6. Ettinghausen SE, Burt ME. Prospective evaluation of unilateral adrenal masses in patient with operable non-small cell lung cancer. J Clin Oncol. 1991;9:462–6.
3.
go back to reference Welch TJ, Sheedy PF, Stephens DH, Johnson CM, Swensen SJ. Percutaneous adrenal biopsy: review of a 10-year experience. Radiology. 1994;193:341–4.CrossRefPubMed Welch TJ, Sheedy PF, Stephens DH, Johnson CM, Swensen SJ. Percutaneous adrenal biopsy: review of a 10-year experience. Radiology. 1994;193:341–4.CrossRefPubMed
4.
go back to reference Dunnick NR, Korobkin M, Francis I. Adrenal radiology: distinguishing benign from malignant adrenal masses. AJR Am J Roentgenol. 1996;167:861–7.CrossRefPubMed Dunnick NR, Korobkin M, Francis I. Adrenal radiology: distinguishing benign from malignant adrenal masses. AJR Am J Roentgenol. 1996;167:861–7.CrossRefPubMed
5.
go back to reference Korobkin M, Brodeur FJ, Yutzy GG, Francis IR, Quint LE, Dunnick NR, et al. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR Am J Roentgenol. 1996;166:531–6.CrossRefPubMed Korobkin M, Brodeur FJ, Yutzy GG, Francis IR, Quint LE, Dunnick NR, et al. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR Am J Roentgenol. 1996;166:531–6.CrossRefPubMed
6.
go back to reference Mitchell DG, Crovello M, Matteucci T, Petersen RO, Miettinen MM. Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology. 1992;185:345–51.CrossRefPubMed Mitchell DG, Crovello M, Matteucci T, Petersen RO, Miettinen MM. Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology. 1992;185:345–51.CrossRefPubMed
7.
go back to reference Korobkin M, Lombardi TJ, Aisen AM, Francis IR, Quint LE, Dunnick NR, et al. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology. 1995;197:411–8.CrossRefPubMed Korobkin M, Lombardi TJ, Aisen AM, Francis IR, Quint LE, Dunnick NR, et al. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology. 1995;197:411–8.CrossRefPubMed
8.
go back to reference Kumar R, Xiu Y, Yu JQ, Takalkar A, El-Haddad G, Potenta S, et al. 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J Nucl Med. 2004;45:2058–62.PubMed Kumar R, Xiu Y, Yu JQ, Takalkar A, El-Haddad G, Potenta S, et al. 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J Nucl Med. 2004;45:2058–62.PubMed
9.
go back to reference Metser U, Miller E, Lerman H, Lievshitz G, Avital S, Even-Sapir E. 18F-FDG PET/CT in the evaluation of adrenal masses. J Nucl Med. 2006;47:32–7.PubMed Metser U, Miller E, Lerman H, Lievshitz G, Avital S, Even-Sapir E. 18F-FDG PET/CT in the evaluation of adrenal masses. J Nucl Med. 2006;47:32–7.PubMed
10.
go back to reference Jana S, Zhang T, Milstein DM, Isasi CR, Blaufox MD. FDG-PET and CT characterization of adrenal lesions in cancer patients. Eur J Nucl Med Mol Imaging. 2006;33:29–35.CrossRefPubMed Jana S, Zhang T, Milstein DM, Isasi CR, Blaufox MD. FDG-PET and CT characterization of adrenal lesions in cancer patients. Eur J Nucl Med Mol Imaging. 2006;33:29–35.CrossRefPubMed
11.
go back to reference Bagheri B, Maurer AH, Cone L, Doss M, Adler L. Characterization of the normal adrenal gland with 18F-FDG PET/CT. J Nucl Med. 2004;45:1340–3.PubMed Bagheri B, Maurer AH, Cone L, Doss M, Adler L. Characterization of the normal adrenal gland with 18F-FDG PET/CT. J Nucl Med. 2004;45:1340–3.PubMed
12.
go back to reference Vincent JM, Morrison ID, Armstrong P, Reznek RH. The size of normal adrenal glands on computed tomography. Clin Radiol. 1994;49:453–5.CrossRefPubMed Vincent JM, Morrison ID, Armstrong P, Reznek RH. The size of normal adrenal glands on computed tomography. Clin Radiol. 1994;49:453–5.CrossRefPubMed
13.
go back to reference Ulrich-Lai YM, Figueiredo HF, Ostrander MM, Choi DC, Engeland WC, Herman JP. Chronic stress induces adrenal hyperplasia and hypertrophy in a subregion-specific manner. Am J Physiol Endocrinol Metab. 2006;291:E965–73.CrossRefPubMed Ulrich-Lai YM, Figueiredo HF, Ostrander MM, Choi DC, Engeland WC, Herman JP. Chronic stress induces adrenal hyperplasia and hypertrophy in a subregion-specific manner. Am J Physiol Endocrinol Metab. 2006;291:E965–73.CrossRefPubMed
14.
go back to reference Erasmus JJ, Patz EF Jr, McAdams HP, Murray JG, Herndon J, Coleman RE, et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol. 1997;168:1357–60.CrossRefPubMed Erasmus JJ, Patz EF Jr, McAdams HP, Murray JG, Herndon J, Coleman RE, et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol. 1997;168:1357–60.CrossRefPubMed
15.
go back to reference Shulkin BL, Thompson NW, Shapiro B, Francis IR, Sisson JC. Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-d-glucose PET. Radiology. 1999;212:35–41.CrossRefPubMed Shulkin BL, Thompson NW, Shapiro B, Francis IR, Sisson JC. Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-d-glucose PET. Radiology. 1999;212:35–41.CrossRefPubMed
16.
go back to reference Brady MJ, Thomas J, Wong TZ, Franklin KM, Ho LM, Paulson EK. Adrenal nodules at FDG PET/CT in patients known to have or suspected of having lung cancer: a proposal for an efficient diagnostic algorithm. Radiology. 2009;250:523–30.CrossRefPubMed Brady MJ, Thomas J, Wong TZ, Franklin KM, Ho LM, Paulson EK. Adrenal nodules at FDG PET/CT in patients known to have or suspected of having lung cancer: a proposal for an efficient diagnostic algorithm. Radiology. 2009;250:523–30.CrossRefPubMed
Metadata
Title
Differentiation of an adrenal mass in patients with non-small cell lung cancer by means of a normal range of adrenal standardized uptake values on FDG PET/CT
Authors
Bom Sahn Kim
Jong Doo Lee
Won Jun Kang
Publication date
01-04-2015
Publisher
Springer Japan
Published in
Annals of Nuclear Medicine / Issue 3/2015
Print ISSN: 0914-7187
Electronic ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-014-0937-3

Other articles of this Issue 3/2015

Annals of Nuclear Medicine 3/2015 Go to the issue